 | • レポートコード：MRC2-11QY11236 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はがん治療のグローバル市場について調査・分析したレポートです。種類別（免疫学的・ワクチン的アプローチ、抗増殖性アプローチ、光線力学療法、遺伝子治療アプローチ、細胞周期・アポトーシスアプローチ）市場規模、用途別（病院、クリニック、家庭、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別がん治療の競争状況、市場シェア ・世界のがん治療市場：種類別市場規模 2015年-2020年（免疫学的・ワクチン的アプローチ、抗増殖性アプローチ、光線力学療法、遺伝子治療アプローチ、細胞周期・アポトーシスアプローチ） ・世界のがん治療市場：種類別市場規模予測 2021年-2026年（免疫学的・ワクチン的アプローチ、抗増殖性アプローチ、光線力学療法、遺伝子治療アプローチ、細胞周期・アポトーシスアプローチ） ・世界のがん治療市場：用途別市場規模 2015年-2020年（病院、クリニック、家庭、その他） ・世界のがん治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、家庭、その他） ・北米のがん治療市場分析：米国、カナダ ・ヨーロッパのがん治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのがん治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のがん治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのがん治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Amgen、AstraZeneca、Bristol-Myers Squibb、Bayer AG、F. Hoffmann-La Roche Ltd、GlaxoSmithKline PLC、Johnson & Johnson、Merck & Co. Inc.、Novartis AG、Pfizer Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cancer therapy describes the treatment of cancer in a patient, often with surgery, chemotherapy and/or radiotherapy. Targeted therapies are also available for some cancer types. A cancer patient might receive many different types of therapy, including those aimed at relieving the symptoms of cancer, such as pain.
North America dominates the global cancer therapy market, owing to high prevalence of cancer in the region because of a sedentary lifestyle, along with launch and growing adoption of novel cancer therapy in the region.
Market Analysis and Insights: Global Cancer Therapies Market
The global Cancer Therapies market size is projected to reach US$ 47430 million by 2026, from US$ 45240 million in 2020, at a CAGR of 4.5%% during 2021-2026.
Global Cancer Therapies Scope and Market Size
Cancer Therapies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Amgen
AstraZeneca
Bristol-Myers Squibb
Bayer AG
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Market segment by Type, the product can be split into
Immunological and Vaccine Approaches
Antiproliferative Approaches
Photodynamic Therapy
Gene Therapy Approaches
Cell Cycle and Apoptosis Approaches
Market segment by Application, split into
Hospital Use
Clinic Use
Household
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Therapies Revenue
1.4 Market by Type
1.4.1 Global Cancer Therapies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunological and Vaccine Approaches
1.4.3 Antiproliferative Approaches
1.4.4 Photodynamic Therapy
1.4.5 Gene Therapy Approaches
1.4.6 Cell Cycle and Apoptosis Approaches
1.5 Market by Application
1.5.1 Global Cancer Therapies Market Share by Application: 2020 VS 2026
1.5.2 Hospital Use
1.5.3 Clinic Use
1.5.4 Household
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cancer Therapies Market Perspective (2015-2026)
2.2 Global Cancer Therapies Growth Trends by Regions
2.2.1 Cancer Therapies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Therapies Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Therapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cancer Therapies Market Growth Strategy
2.3.6 Primary Interviews with Key Cancer Therapies Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cancer Therapies Players by Market Size
3.1.1 Global Top Cancer Therapies Players by Revenue (2015-2020)
3.1.2 Global Cancer Therapies Revenue Market Share by Players (2015-2020)
3.1.3 Global Cancer Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Therapies Market Concentration Ratio
3.2.1 Global Cancer Therapies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cancer Therapies Revenue in 2019
3.3 Cancer Therapies Key Players Head office and Area Served
3.4 Key Players Cancer Therapies Product Solution and Service
3.5 Date of Enter into Cancer Therapies Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cancer Therapies Historic Market Size by Type (2015-2020)
4.2 Global Cancer Therapies Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cancer Therapies Market Size by Application (2015-2020)
5.2 Global Cancer Therapies Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cancer Therapies Market Size (2015-2020)
6.2 Cancer Therapies Key Players in North America (2019-2020)
6.3 North America Cancer Therapies Market Size by Type (2015-2020)
6.4 North America Cancer Therapies Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cancer Therapies Market Size (2015-2020)
7.2 Cancer Therapies Key Players in Europe (2019-2020)
7.3 Europe Cancer Therapies Market Size by Type (2015-2020)
7.4 Europe Cancer Therapies Market Size by Application (2015-2020)
8 China
8.1 China Cancer Therapies Market Size (2015-2020)
8.2 Cancer Therapies Key Players in China (2019-2020)
8.3 China Cancer Therapies Market Size by Type (2015-2020)
8.4 China Cancer Therapies Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cancer Therapies Market Size (2015-2020)
9.2 Cancer Therapies Key Players in Japan (2019-2020)
9.3 Japan Cancer Therapies Market Size by Type (2015-2020)
9.4 Japan Cancer Therapies Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cancer Therapies Market Size (2015-2020)
10.2 Cancer Therapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Therapies Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Therapies Market Size by Application (2015-2020)
11 India
11.1 India Cancer Therapies Market Size (2015-2020)
11.2 Cancer Therapies Key Players in India (2019-2020)
11.3 India Cancer Therapies Market Size by Type (2015-2020)
11.4 India Cancer Therapies Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cancer Therapies Market Size (2015-2020)
12.2 Cancer Therapies Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Therapies Market Size by Type (2015-2020)
12.4 Central & South America Cancer Therapies Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Amgen
13.1.1 Amgen Company Details
13.1.2 Amgen Business Overview
13.1.3 Amgen Cancer Therapies Introduction
13.1.4 Amgen Revenue in Cancer Therapies Business (2015-2020))
13.1.5 Amgen Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview
13.2.3 AstraZeneca Cancer Therapies Introduction
13.2.4 AstraZeneca Revenue in Cancer Therapies Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Company Details
13.3.2 Bristol-Myers Squibb Business Overview
13.3.3 Bristol-Myers Squibb Cancer Therapies Introduction
13.3.4 Bristol-Myers Squibb Revenue in Cancer Therapies Business (2015-2020)
13.3.5 Bristol-Myers Squibb Recent Development
13.4 Bayer AG
13.4.1 Bayer AG Company Details
13.4.2 Bayer AG Business Overview
13.4.3 Bayer AG Cancer Therapies Introduction
13.4.4 Bayer AG Revenue in Cancer Therapies Business (2015-2020)
13.4.5 Bayer AG Recent Development
13.5 F. Hoffmann-La Roche Ltd
13.5.1 F. Hoffmann-La Roche Ltd Company Details
13.5.2 F. Hoffmann-La Roche Ltd Business Overview
13.5.3 F. Hoffmann-La Roche Ltd Cancer Therapies Introduction
13.5.4 F. Hoffmann-La Roche Ltd Revenue in Cancer Therapies Business (2015-2020)
13.5.5 F. Hoffmann-La Roche Ltd Recent Development
13.6 GlaxoSmithKline PLC
13.6.1 GlaxoSmithKline PLC Company Details
13.6.2 GlaxoSmithKline PLC Business Overview
13.6.3 GlaxoSmithKline PLC Cancer Therapies Introduction
13.6.4 GlaxoSmithKline PLC Revenue in Cancer Therapies Business (2015-2020)
13.6.5 GlaxoSmithKline PLC Recent Development
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Details
13.7.2 Johnson & Johnson Business Overview
13.7.3 Johnson & Johnson Cancer Therapies Introduction
13.7.4 Johnson & Johnson Revenue in Cancer Therapies Business (2015-2020)
13.7.5 Johnson & Johnson Recent Development
13.8 Merck & Co. Inc.
13.8.1 Merck & Co. Inc. Company Details
13.8.2 Merck & Co. Inc. Business Overview
13.8.3 Merck & Co. Inc. Cancer Therapies Introduction
13.8.4 Merck & Co. Inc. Revenue in Cancer Therapies Business (2015-2020)
13.8.5 Merck & Co. Inc. Recent Development
13.9 Novartis AG
13.9.1 Novartis AG Company Details
13.9.2 Novartis AG Business Overview
13.9.3 Novartis AG Cancer Therapies Introduction
13.9.4 Novartis AG Revenue in Cancer Therapies Business (2015-2020)
13.9.5 Novartis AG Recent Development
13.10 Pfizer Inc.
13.10.1 Pfizer Inc. Company Details
13.10.2 Pfizer Inc. Business Overview
13.10.3 Pfizer Inc. Cancer Therapies Introduction
13.10.4 Pfizer Inc. Revenue in Cancer Therapies Business (2015-2020)
13.10.5 Pfizer Inc. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cancer Therapies Key Market Segments
Table 2. Key Players Covered: Ranking by Cancer Therapies Revenue
Table 3. Ranking of Global Top Cancer Therapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancer Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunological and Vaccine Approaches
Table 6. Key Players of Antiproliferative Approaches
Table 7. Key Players of Photodynamic Therapy
Table 8. Key Players of Gene Therapy Approaches
Table 9. Key Players of Cell Cycle and Apoptosis Approaches
Table 10. Global Cancer Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Cancer Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Cancer Therapies Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Cancer Therapies Market Share by Regions (2015-2020)
Table 14. Global Cancer Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Cancer Therapies Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Cancer Therapies Market Growth Strategy
Table 20. Main Points Interviewed from Key Cancer Therapies Players
Table 21. Global Cancer Therapies Revenue by Players (2015-2020) (Million US$)
Table 22. Global Cancer Therapies Market Share by Players (2015-2020)
Table 23. Global Top Cancer Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Therapies as of 2019)
Table 24. Global Cancer Therapies by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Cancer Therapies Product Solution and Service
Table 27. Date of Enter into Cancer Therapies Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Cancer Therapies Market Size by Type (2015-2020) (Million US$)
Table 30. Global Cancer Therapies Market Size Share by Type (2015-2020)
Table 31. Global Cancer Therapies Revenue Market Share by Type (2021-2026)
Table 32. Global Cancer Therapies Market Size Share by Application (2015-2020)
Table 33. Global Cancer Therapies Market Size by Application (2015-2020) (Million US$)
Table 34. Global Cancer Therapies Market Size Share by Application (2021-2026)
Table 35. North America Key Players Cancer Therapies Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Cancer Therapies Market Share (2019-2020)
Table 37. North America Cancer Therapies Market Size by Type (2015-2020) (Million US$)
Table 38. North America Cancer Therapies Market Share by Type (2015-2020)
Table 39. North America Cancer Therapies Market Size by Application (2015-2020) (Million US$)
Table 40. North America Cancer Therapies Market Share by Application (2015-2020)
Table 41. Europe Key Players Cancer Therapies Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Cancer Therapies Market Share (2019-2020)
Table 43. Europe Cancer Therapies Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Cancer Therapies Market Share by Type (2015-2020)
Table 45. Europe Cancer Therapies Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Cancer Therapies Market Share by Application (2015-2020)
Table 47. China Key Players Cancer Therapies Revenue (2019-2020) (Million US$)
Table 48. China Key Players Cancer Therapies Market Share (2019-2020)
Table 49. China Cancer Therapies Market Size by Type (2015-2020) (Million US$)
Table 50. China Cancer Therapies Market Share by Type (2015-2020)
Table 51. China Cancer Therapies Market Size by Application (2015-2020) (Million US$)
Table 52. China Cancer Therapies Market Share by Application (2015-2020)
Table 53. Japan Key Players Cancer Therapies Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Cancer Therapies Market Share (2019-2020)
Table 55. Japan Cancer Therapies Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Cancer Therapies Market Share by Type (2015-2020)
Table 57. Japan Cancer Therapies Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Cancer Therapies Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Cancer Therapies Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Cancer Therapies Market Share (2019-2020)
Table 61. Southeast Asia Cancer Therapies Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Cancer Therapies Market Share by Type (2015-2020)
Table 63. Southeast Asia Cancer Therapies Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Cancer Therapies Market Share by Application (2015-2020)
Table 65. India Key Players Cancer Therapies Revenue (2019-2020) (Million US$)
Table 66. India Key Players Cancer Therapies Market Share (2019-2020)
Table 67. India Cancer Therapies Market Size by Type (2015-2020) (Million US$)
Table 68. India Cancer Therapies Market Share by Type (2015-2020)
Table 69. India Cancer Therapies Market Size by Application (2015-2020) (Million US$)
Table 70. India Cancer Therapies Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Cancer Therapies Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Cancer Therapies Market Share (2019-2020)
Table 73. Central & South America Cancer Therapies Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Cancer Therapies Market Share by Type (2015-2020)
Table 75. Central & South America Cancer Therapies Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Cancer Therapies Market Share by Application (2015-2020)
Table 77. Amgen Company Details
Table 78. Amgen Business Overview
Table 79. Amgen Product
Table 80. Amgen Revenue in Cancer Therapies Business (2015-2020) (Million US$)
Table 81. Amgen Recent Development
Table 82. AstraZeneca Company Details
Table 83. AstraZeneca Business Overview
Table 84. AstraZeneca Product
Table 85. AstraZeneca Revenue in Cancer Therapies Business (2015-2020) (Million US$)
Table 86. AstraZeneca Recent Development
Table 87. Bristol-Myers Squibb Company Details
Table 88. Bristol-Myers Squibb Business Overview
Table 89. Bristol-Myers Squibb Product
Table 90. Bristol-Myers Squibb Revenue in Cancer Therapies Business (2015-2020) (Million US$)
Table 91. Bristol-Myers Squibb Recent Development
Table 92. Bayer AG Company Details
Table 93. Bayer AG Business Overview
Table 94. Bayer AG Product
Table 95. Bayer AG Revenue in Cancer Therapies Business (2015-2020) (Million US$)
Table 96. Bayer AG Recent Development
Table 97. F. Hoffmann-La Roche Ltd Company Details
Table 98. F. Hoffmann-La Roche Ltd Business Overview
Table 99. F. Hoffmann-La Roche Ltd Product
Table 100. F. Hoffmann-La Roche Ltd Revenue in Cancer Therapies Business (2015-2020) (Million US$)
Table 101. F. Hoffmann-La Roche Ltd Recent Development
Table 102. GlaxoSmithKline PLC Company Details
Table 103. GlaxoSmithKline PLC Business Overview
Table 104. GlaxoSmithKline PLC Product
Table 105. GlaxoSmithKline PLC Revenue in Cancer Therapies Business (2015-2020) (Million US$)
Table 106. GlaxoSmithKline PLC Recent Development
Table 107. Johnson & Johnson Company Details
Table 108. Johnson & Johnson Business Overview
Table 109. Johnson & Johnson Product
Table 110. Johnson & Johnson Revenue in Cancer Therapies Business (2015-2020) (Million US$)
Table 111. Johnson & Johnson Recent Development
Table 112. Merck & Co. Inc. Business Overview
Table 113. Merck & Co. Inc. Product
Table 114. Merck & Co. Inc. Company Details
Table 115. Merck & Co. Inc. Revenue in Cancer Therapies Business (2015-2020) (Million US$)
Table 116. Merck & Co. Inc. Recent Development
Table 117. Novartis AG Company Details
Table 118. Novartis AG Business Overview
Table 119. Novartis AG Product
Table 120. Novartis AG Revenue in Cancer Therapies Business (2015-2020) (Million US$)
Table 121. Novartis AG Recent Development
Table 122. Pfizer Inc. Company Details
Table 123. Pfizer Inc. Business Overview
Table 124. Pfizer Inc. Product
Table 125. Pfizer Inc. Revenue in Cancer Therapies Business (2015-2020) (Million US$)
Table 126. Pfizer Inc. Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Therapies Market Share by Type: 2020 VS 2026
Figure 2. Immunological and Vaccine Approaches Features
Figure 3. Antiproliferative Approaches Features
Figure 4. Photodynamic Therapy Features
Figure 5. Gene Therapy Approaches Features
Figure 6. Cell Cycle and Apoptosis Approaches Features
Figure 7. Global Cancer Therapies Market Share by Application: 2020 VS 2026
Figure 8. Hospital Use Case Studies
Figure 9. Clinic Use Case Studies
Figure 10. Household Case Studies
Figure 11. Other Case Studies
Figure 12. Cancer Therapies Report Years Considered
Figure 13. Global Cancer Therapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Cancer Therapies Market Share by Regions: 2020 VS 2026
Figure 15. Global Cancer Therapies Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Cancer Therapies Market Share by Players in 2019
Figure 18. Global Top Cancer Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Therapies as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Cancer Therapies Revenue in 2019
Figure 20. North America Cancer Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Cancer Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Cancer Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Cancer Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Cancer Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Cancer Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Cancer Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
精密がん治療の世界市場（～2026年） Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy. Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormali…- 子宮頸がん治療法・診断の世界市場（～2026年） Therapies and Diagnostics for Cervical Cancer refers to a series of methods and medical devices that can be used for the diagnosis and treatment of cervical cancer. The factors that are driving the cervical cancer market are HPV infection, women having many sexual partners, women getting sexually ac…
- 卵巣がん遺伝子治療の世界市場（～2026年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- がん幹細胞治療の世界市場（～2026年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Stem Cell Therapy Scope and Market Size Cancer Stem Cell T…
- がん遺伝子治療の世界市場（～2026年） Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has be…